Biocompatibility of Orthopaedic Implants | Orthopaedic Surgery Grand Rounds (RECORDING)


Biocompatibility of Orthopaedic Implants | Orthopaedic Surgery Grand Rounds (RECORDING) Banner



Date & Location
Thursday, September 26, 2024, 12:00 AM - Sunday, September 26, 2027, 11:59 PM, On Demand

Overview
In this recorded Orthopaedic Grand Rounds presentation, Dr. Stuart B. Goodman, an orthopedic surgeon and researcher, covers his career journey, research work, and insights into inflammation, particle disease, bone healing, and the future of orthopedics. He discusses his mentors, early work on particle disease and osteolysis caused by wear debris, and the transition to studying inflammation's role in bone healing and regeneration. In addition, he presents the latest research using single-cell analysis, joint-on-a-chip models, and modulating inflammation for better healing. Overall, the presentation includes the importance of inflammation in initiating healing, the potential of biologics and combination products, and a multidisciplinary approach combining biomechanics, biology, and biomaterials for advancing orthopedics.



Registration

  Release Date: September 26th, 2024
  Expiration Date: September 25th, 2027
  Estimated Time to Complete: 0.50 hours
  Registration Fee: FREE
 *Originally recorded 02/01/2023


Credits
AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Participation Credit (0.50 hours)

Target Audience
Specialties - Orthopedics & Sports Medicine, Surgery
Professions - Fellow/Resident, Physician

Objectives
At the conclusion of this activity, learners should be able to:

  1. Develop biologics and combination products to modulate inflammation and promote bone healing and regeneration.
  2. Utilize single-cell analysis techniques, such as mass cytometry and RNA sequencing, to understand cell interactions and pathways in bone healing.
  3. Explore the joint-on-a-chip model for high-throughput drug screening and testing potential therapies for orthopedic conditions.
  4. Collaborate with experts in biomechanics, biology, and biomaterials to advance a multidisciplinary approach in orthopedics.
  5. Continue research on modulating macrophages and genetically modifying mesenchymal stem cells (MSCs) to enhance their therapeutic potential in bone healing and regeneration.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  


Additional Information

Accessibility Statement
  Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For References/Bibliography, click here.

For CME general questions, please contact 
     Email: [email protected]